655 related articles for article (PubMed ID: 21923713)
1. Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
Kim YS; Kim SJ; Yoon JH; Suk KT; Kim JB; Kim DJ; Kim DY; Min HJ; Park SH; Shin WG; Kim KH; Kim HY; Baik GH
Aliment Pharmacol Ther; 2011 Nov; 34(9):1098-105. PubMed ID: 21923713
[TBL] [Abstract][Full Text] [Related]
2. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study.
Oh HS; Lee DH; Seo JY; Cho YR; Kim N; Jeoung SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Cho HJ; Jung HC; Song IS
J Gastroenterol Hepatol; 2012 Mar; 27(3):504-9. PubMed ID: 21916989
[TBL] [Abstract][Full Text] [Related]
3. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
4. Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
Park HG; Jung MK; Jung JT; Kwon JG; Kim EY; Seo HE; Lee JH; Yang CH; Kim ES; Cho KB; Park KS; Lee SH; Kim KO; Jeon SW
Aliment Pharmacol Ther; 2012 Jan; 35(1):56-65. PubMed ID: 22066530
[TBL] [Abstract][Full Text] [Related]
5. Sequential therapy achieves a higher eradication rate than standard triple therapy in Taiwan.
Tsay FW; Tseng HH; Hsu PI; Wang KM; Lee CC; Chang SN; Wang HM; Yu HC; Chen WC; Peng NJ; Lai KH; Wu DC
J Gastroenterol Hepatol; 2012 Mar; 27(3):498-503. PubMed ID: 21871025
[TBL] [Abstract][Full Text] [Related]
6. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
Chung JW; Jung YK; Kim YJ; Kwon KA; Kim JH; Lee JJ; Lee SM; Hahm KB; Lee SM; Jeong JY; Yun SC
J Gastroenterol Hepatol; 2012 Nov; 27(11):1675-80. PubMed ID: 22849546
[TBL] [Abstract][Full Text] [Related]
7. Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study.
Kwon JH; Lee DH; Song BJ; Lee JW; Kim JJ; Park YS; Kim N; Jeong SH; Kim JW; Lee SH; Hwang JH; Jung HC; Song IS
Helicobacter; 2010 Apr; 15(2):148-53. PubMed ID: 20402817
[TBL] [Abstract][Full Text] [Related]
8. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
[TBL] [Abstract][Full Text] [Related]
9. A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea.
Lee JW; Kim N; Kim JM; Nam RH; Kim JY; Lee JY; Lee DH; Jung HC
Scand J Gastroenterol; 2014 Aug; 49(8):917-24. PubMed ID: 24988873
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
Zheng Q; Pan Y; Zhang L; Xiao SD
Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study.
Lim JH; Lee DH; Choi C; Lee ST; Kim N; Jeong SH; Kim JW; Hwang JH; Park YS; Lee SH; Shin CM; Jo HJ; Jang ES; Song Is; Jung HC
Helicobacter; 2013 Jun; 18(3):180-6. PubMed ID: 23305083
[TBL] [Abstract][Full Text] [Related]
13. Neither 10- nor 14-Day Sequential Treatment is better than Standard Triple Therapy for Helicobacter Pylori Eradication.
Warrington E; López-Román O; Tirado Montijo R; Urbina R; Cruz-Correa M; Toro DH
P R Health Sci J; 2016 Dec; 35(4):203-208. PubMed ID: 27898166
[TBL] [Abstract][Full Text] [Related]
14. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.
Greenberg ER; Anderson GL; Morgan DR; Torres J; Chey WD; Bravo LE; Dominguez RL; Ferreccio C; Herrero R; Lazcano-Ponce EC; Meza-Montenegro MM; Peña R; Peña EM; Salazar-Martínez E; Correa P; Martínez ME; Valdivieso M; Goodman GE; Crowley JJ; Baker LH
Lancet; 2011 Aug; 378(9790):507-14. PubMed ID: 21777974
[TBL] [Abstract][Full Text] [Related]
15. Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice.
Sánchez-Delgado J; Calvet X; Bujanda L; Gisbert JP; Titó L; Castro M
Am J Gastroenterol; 2008 Sep; 103(9):2220-3. PubMed ID: 18564109
[TBL] [Abstract][Full Text] [Related]
16. Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naïve and retreat patients.
Abuhammour A; Dajani A; Nounou M; Zakaria M
Arab J Gastroenterol; 2016 Sep; 17(3):131-136. PubMed ID: 27665525
[TBL] [Abstract][Full Text] [Related]
17. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.
Kim BG; Lee DH; Ye BD; Lee KH; Kim BW; Kim SG; Kim SW; Kim SK; Kim JJ; Kim HY; Park JJ; Park CY; Baik GH; Lee YC; Lee JH; Lee JH; Chun HJ; Hahm KB; Hong SJ; Lee SW; Jung HC
Helicobacter; 2007 Feb; 12(1):31-5. PubMed ID: 17241298
[TBL] [Abstract][Full Text] [Related]
19. Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate--a placebo-controlled study.
Nseir W; Diab H; Mahamid M; Abu-Elheja O; Samara M; Abid A; Mograbi J
Aliment Pharmacol Ther; 2012 Aug; 36(3):231-8. PubMed ID: 22646167
[TBL] [Abstract][Full Text] [Related]
20. Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial.
Tsay FW; Wu DC; Kao SS; Tsai TJ; Lai KH; Cheng JS; Chan HH; Wang HM; Tsai WL; Tseng HH; Peng NJ; Hsu PI
Helicobacter; 2015 Feb; 20(1):71-7. PubMed ID: 25495272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
